Moderna’s mRNA Vaccine Candidate Prevents RSV-Associated Disease in Older Adults
Results showed vaccine efficacy of 83.7% against RSV-LRTD, defined by 2 or more symptoms.
Results showed vaccine efficacy of 83.7% against RSV-LRTD, defined by 2 or more symptoms.
Findings were consistent for patients aged 80 years or older and patients with chronic kidney disease, who are often underrepresented in clinical trials.
The association is revealed in a study of more 444,000 US veterans with new-onset chronic kidney disease.
A review of geriatric assessment tools and their role in assessing older patients with cancer before and after treatment.
The RSVpreF vaccine candidate consists of 2 prefusion F proteins selected to optimize protection against RSV A and B.
Clinicians need to be aware of their assumptions about patients based on age.
Patients’ life expectancy should be considered when deciding whether to intensify hypertension treatment, according to investigators.
The long-term extension phase of the phase 3 EMERGE and ENGAGE trials evaluated the efficacy and safety of aducanumab-avwa in adults aged 50 to 85 years with early Alzheimer disease.
Adlarity is a once-weekly transdermal formulation of donepezil that is designed to be worn for 7 days with consistent adhesion.
Foods rich in calcium and protein like milk, yogurt, and cheese slow bone loss and improve insulin-like growth factor 1, which promotes bone and tissue growth. Researchers studied whether adding these to the diets of people aged 80 and older at care facilities would decrease their risk of hip fractures and falls.